p53 As a prognostic indicator in endometrial cancer

Gynecologic Oncology

Volumn 61, Issue 2, 1996, Pages 245-248

  Geisler, John P ^a   Wiemann, Michael C ^a   Zhou, Zhen ^b   Miller, Greg A ^b   Geisler, Hans E ^a  

^a ST VINCENT HOSPITAL   (United States)

^b Dept Pathol Lab Diagn Analyt C ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0029883659     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0133     Document Type: Article

References (18)

1. Knudson, A. G. Mutation and cancer - Statistical study of retinoblastoma, Proc. Natl Acad. Sci. USA 68, 820-823 (1971).
2. Purdie, C. A., O'Grady, J., Piris, J., Wyllie, A. H., and Bird, C. C. p53 expression in colorectal tumors, Am. J. Pathol. 138, 807-813 (1991).
3. Levine, A. J. The role of p53 as a tumor suppressor gene in human cancers, Adv. Oncol. 8, 3-9 (1993).
4. Berchuck, A., Kohler, M. F., Marks, J. R., Wiseman, R., Boyd, J., and Bast, R. C. The p53 tumor suppressor gene frequently is altered in gynecologic cancers, Am. J. Obstet. Gynecol. 170, 246-252 (1994).
5. Bur, M. E., Perlman, C., Edelmann, L., Fey, E., and Rose, P. G. p53 expression in neoplasms of the uterine corpus, Am. J. Clin. Pathol. 98, 81-87 (1992).
6. Ambros, R. A., Vigna, P. A., Figge, J., Kallakury, B. V. S., Mastrangelo, A., Eastman, A. Y., Malfetano, J., Figge, H. L., and Ross, J. S. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53, Cancer 73, 1686-1692 (1994).
7. Kohler, M. F., Berchuck, A., Davidoff, A. M., Humphrey, P. A., Dodge, R. K., Iglehart, J. D., Soper, J. T., Clarke-Pearson, D. L., Bast, R. C., and Marks, J. R. Overexpression and mutation of p53 in endometrial carcinoma, Cancer Res. 152, 1622-1627 (1992).
8. Reinartz, J. J., George, E., Lindgren, B. R., and Niehans, G. A. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival, Hum. Pathol. 25, 1075-1083 (1994).
9. Khalifa, M. A., Mannel, R. S., Haraway, S. D., Walker, J., and Min, K. W. Expression of EGFR, HER-2/neu, p53, and PCNA in endometrioid, serous papillary and clear cell endometrial adenocarcinomas, Gynecol. Oncol. 53, 84-92 (1994).
10. DiSaia, P. J., and Creasman, W. T. Adenocarcinoma of the uterus, in Clinical gynecologic oncology, Mosby Year Book, St. Louis, 4th ed., pp 156-193 (1993).
11. Creasman, W. T., and Rutledge, F. The prognostic value of peritoneal cytology in gynecologic malignant disease, Am. J. Obstet. Gynecol. 110, 773-781 (1971).
12. Hanson, M. B., Van Nagell, J. R., Powell, D. E., Donaldson, E. S., Gallion, H., Merhige, M., and Pavlik, E. J. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer, Cancer 55, 1753-1757 (1985).
13. Geisinger, K. R., Homesley, H. D., Morgan, T. M., Kute, T. E., and Marshall, R. B. Endometrial carcinoma: a multiparameter clinicopathologic analysis including the DNA profile and the sex steroid status, Cancer 58, 1518-1525 (1986).
14. Iversen, O. E. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma, Am. J. Obstet. Gynecol. 155, 770-776 (1986).
15. Britton, L. C., Wilson, T. O., Gaffey, T. A., Lieber, M. M., Wieand, H. S., and Podratz, K. C. Flow cytometric DNA analysis of stage I endometrial carcinoma, Gynecol. Oncol. 34, 317-322 (1989).
16. Britton, L. C., Wilson, T. O., Gaffey, T. A., Cha, S. S., Wieand, H. S., and Podratz, K. C. DNA ploidy in endometrial carcinoma: major objective prognostic factor, Mayo Clin. Proc. 65, 643-650 (1990).
17. Kraiss, S., Spiess, S., Reihaus, E., and Montenarh, M. Correlation of metabolic stability and altered quaternary structure of oncoprotein p53 with cell transformation, Exp. Cell. Res. 192, 157-164 (1991).
18. Azumi, N., and Czernobilsky, B. Immunohistochemistry, in Blaustein's Pathology of the female genital tract (R. J. Kurman, Ed.), Springer-Verlag, New York, 4th ed., pp 1131-1160 (1994).